Drug Type Small molecule drug |
Synonyms- |
Target- |
Mechanism Cell proliferation inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H36ClN2O7P |
InChIKeyVVFIROBUUUZQCR-UHFFFAOYSA-N |
CAS Registry2445800-65-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Preclinical | CN | 01 May 2020 |